skip to main content
Show Results with:
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Phase I trials in patients with relapsed, advanced upper gastrointestinal carcinomas: experience in a specialist unit

Gastric Cancer, 2014, Vol.17(4), pp.621-629 [Peer Reviewed Journal]

Full text available

View all versions
2
Material Type:
Article
Add to My workspace

Quality of life of older adult patients receiving docetaxel-based chemotherapy triplets for esophagogastric adenocarcinoma: a randomized study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Gastric Cancer, 2014, Vol.17(1), pp.181-187 [Peer Reviewed Journal]

Full text available

View all versions
3
Material Type:
Article
Add to My workspace

Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer

Gastric Cancer, 2017, Vol.20(1), pp.182-189 [Peer Reviewed Journal]

Full text available

View all versions
4
Material Type:
Article
Add to My workspace

A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer

Gastric Cancer, Jan 2014, Vol.17(1), pp.161-72 [Peer Reviewed Journal]

No full-text

View all versions
5
Material Type:
Article
Add to My workspace

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer

Gastric Cancer, Jan 2016, Vol.19(1), pp.234-244 [Peer Reviewed Journal]

No full-text

View all versions
6
Material Type:
Article
Add to My workspace

A feasibility study of outpatient chemotherapy with S-1 + cisplatin in patients with advanced gastric cancer

Gastric Cancer, 2013, Vol.16(1), pp.41-47 [Peer Reviewed Journal]

Full text available

View all versions
7
Material Type:
Article
Add to My workspace

Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival

Gastric Cancer, 2013, Vol.16(4), pp.581-589 [Peer Reviewed Journal]

Full text available

View all versions
8
Material Type:
Article
Add to My workspace

Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G)

Gastric Cancer, 2018, Vol.21(1), pp.84-95 [Peer Reviewed Journal]

Full text available

View all versions
9
Material Type:
Article
Add to My workspace

Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry

Gastric Cancer, 2018, Vol.21(1), pp.96-105 [Peer Reviewed Journal]

Full text available

View all versions
10
Material Type:
Article
Add to My workspace

Safety, pharmacokinetic, and clinical activity profiles of ramucirumab in combination with three platinum/fluoropyrimidine doublets in Japanese patients with chemotherapy-naïve metastatic gastric/gastroesophageal junction cancer

Gastric Cancer, Jan 2018, Vol.21(1), pp.106-113 [Peer Reviewed Journal]

No full-text

View all versions

Refine Search Results

Try a new search

Ignore my search and look for everything

by this Author/Contributor:

  1. Yamada, Yasuhide
  2. Kato, Ken
  3. Ryoo, Baek-Yeol
  4. Lacalle, A.
  5. Echavarria, I.

Searching Remote Databases, Please Wait